APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cardiac Marker

Compare research editions
View pricing & licenses

Selected research

Industry Research

Cardiac Marker Industry Research Report 2026

Report ID 173975080520 December 2025123 pages

Choose your research edition.

Industry ResearchCardiac Marker Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Cardiac Marker Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Cardiac Marker Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cardiac Marker Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Cardiac Marker Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Cardiac Marker market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Cardiac Marker is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Cardiac Marker is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Cardiac Marker is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Cardiac Marker include BG Medicine, Biomerieux, Critical Diagnostics, DiaDexus, HyTest, Lee BioSolutions, Response Biomedical, Roche Diagnostics and Siemens Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Cardiac Marker market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Cardiac Marker Market by Company

BG Medicine

Biomerieux

Critical Diagnostics

DiaDexus

HyTest

Lee BioSolutions

Response Biomedical

Roche Diagnostics

Siemens Healthcare

Singulex

Sunfory

Thermo Scientific

Trinity Biotech

Abbott

Cardiac Marker Segment by Type

BNP & NT-proBNP

Troponin (cTnI and cTnT)

Myogloblin

Creatine kinase (CK) MB

Others (hs-CRP, D-Dimer, etc.)

Cardiac Marker Segment by Application

Myocardial Infarction

Acute Coronary Syndrome

Atherosclerosis

Congestive Heart Failure

Others

Cardiac Marker Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cardiac Marker market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cardiac Marker and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cardiac Marker.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Cardiac Marker manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Cardiac Marker by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Cardiac Marker in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Cardiac Marker Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Cardiac Marker Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Cardiac Marker Sales Market Share by Manufacturers (2021-2026) Table 8. Global Cardiac Marker Revenue of Manufacturers (2021-2026) Table 9. Global Cardiac Marker Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Cardiac Marker Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Cardiac Marker Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Cardiac Marker, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Cardiac Marker, Product Type & Application Table 14. Global Cardiac Marker Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Cardiac Marker by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. BG Medicine Company Information Table 19. BG Medicine Business Overview Table 20. BG Medicine Cardiac Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. BG Medicine Cardiac Marker Product Portfolio Table 22. BG Medicine Recent Developments Table 23. Biomerieux Company Information Table 24. Biomerieux Business Overview Table 25. Biomerieux Cardiac Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Biomerieux Cardiac Marker Product Portfolio Table 27. Biomerieux Recent Developments Table 28. Critical Diagnostics Company Information Table 29. Critical Diagnostics Business Overview Table 30. Critical Diagnostics Cardiac Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Critical Diagnostics Cardiac Marker Product Portfolio Table 32. Critical Diagnostics Recent Developments Table 33. DiaDexus Company Information Table 34. DiaDexus Business Overview Table 35. DiaDexus Cardiac Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. DiaDexus Cardiac Marker Product Portfolio Table 37. DiaDexus Recent Developments Table 38. HyTest Company Information Table 39. HyTest Business Overview Table 40. HyTest Cardiac Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. HyTest Cardiac Marker Product Portfolio Table 42. HyTest Recent Developments Table 43. Lee BioSolutions Company Information Table 44. Lee BioSolutions Business Overview Table 45. Lee BioSolutions Cardiac Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Lee BioSolutions Cardiac Marker Product Portfolio Table 47. Lee BioSolutions Recent Developments Table 48. Response Biomedical Company Information Table 49. Response Biomedical Business Overview Table 50. Response Biomedical Cardiac Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Response Biomedical Cardiac Marker Product Portfolio Table 52. Response Biomedical Recent Developments Table 53. Roche Diagnostics Company Information Table 54. Roche Diagnostics Business Overview Table 55. Roche Diagnostics Cardiac Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Roche Diagnostics Cardiac Marker Product Portfolio Table 57. Roche Diagnostics Recent Developments Table 58. Siemens Healthcare Company Information Table 59. Siemens Healthcare Business Overview Table 60. Siemens Healthcare Cardiac Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Siemens Healthcare Cardiac Marker Product Portfolio Table 62. Siemens Healthcare Recent Developments Table 63. Singulex Company Information Table 64. Singulex Business Overview Table 65. Singulex Cardiac Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Singulex Cardiac Marker Product Portfolio Table 67. Singulex Recent Developments Table 68. Sunfory Company Information Table 69. Sunfory Business Overview Table 70. Sunfory Cardiac Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Sunfory Cardiac Marker Product Portfolio Table 72. Sunfory Recent Developments Table 73. Thermo Scientific Company Information Table 74. Thermo Scientific Business Overview Table 75. Thermo Scientific Cardiac Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Thermo Scientific Cardiac Marker Product Portfolio Table 77. Thermo Scientific Recent Developments Table 78. Trinity Biotech Company Information Table 79. Trinity Biotech Business Overview Table 80. Trinity Biotech Cardiac Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Trinity Biotech Cardiac Marker Product Portfolio Table 82. Trinity Biotech Recent Developments Table 83. Abbott Company Information Table 84. Abbott Business Overview Table 85. Abbott Cardiac Marker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Abbott Cardiac Marker Product Portfolio Table 87. Abbott Recent Developments Table 88. Global Cardiac Marker Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 89. Global Cardiac Marker Sales by Region (2021-2026) & (K Units) Table 90. Global Cardiac Marker Sales Market Share by Region (2021-2026) Table 91. Global Cardiac Marker Sales by Region (2027-2032) & (K Units) Table 92. Global Cardiac Marker Sales Market Share by Region (2027-2032) Table 93. Global Cardiac Marker Revenue by Region (2021-2026) & (US$ Million) Table 94. Global Cardiac Marker Revenue Market Share by Region (2021-2026) Table 95. Global Cardiac Marker Revenue by Region (2027-2032) & (US$ Million) Table 96. Global Cardiac Marker Revenue Market Share by Region (2027-2032) Table 97. North America Cardiac Marker Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. North America Cardiac Marker Sales by Country (2021-2026) & (K Units) Table 99. North America Cardiac Marker Sales by Country (2027-2032) & (K Units) Table 100. North America Cardiac Marker Revenue by Country (2021-2026) & (US$ Million) Table 101. North America Cardiac Marker Revenue by Country (2027-2032) & (US$ Million) Table 102. Europe Cardiac Marker Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Europe Cardiac Marker Sales by Country (2021-2026) & (K Units) Table 104. Europe Cardiac Marker Sales by Country (2027-2032) & (K Units) Table 105. Europe Cardiac Marker Revenue by Country (2021-2026) & (US$ Million) Table 106. Europe Cardiac Marker Revenue by Country (2027-2032) & (US$ Million) Table 107. Asia Pacific Cardiac Marker Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Asia Pacific Cardiac Marker Sales by Country (2021-2026) & (K Units) Table 109. Asia Pacific Cardiac Marker Sales by Country (2027-2032) & (K Units) Table 110. Asia Pacific Cardiac Marker Revenue by Country (2021-2026) & (US$ Million) Table 111. Asia Pacific Cardiac Marker Revenue by Country (2027-2032) & (US$ Million) Table 112. South America Cardiac Marker Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. South America Cardiac Marker Sales by Country (2021-2026) & (K Units) Table 114. South America Cardiac Marker Sales by Country (2027-2032) & (K Units) Table 115. South America Cardiac Marker Revenue by Country (2021-2026) & (US$ Million) Table 116. South America Cardiac Marker Revenue by Country (2027-2032) & (US$ Million) Table 117. Middle East and Africa Cardiac Marker Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Middle East and Africa Cardiac Marker Sales by Country (2021-2026) & (K Units) Table 119. Middle East and Africa Cardiac Marker Sales by Country (2027-2032) & (K Units) Table 120. Middle East and Africa Cardiac Marker Revenue by Country (2021-2026) & (US$ Million) Table 121. Middle East and Africa Cardiac Marker Revenue by Country (2027-2032) & (US$ Million) Table 122. Global Cardiac Marker Sales by Type (2021-2026) & (K Units) Table 123. Global Cardiac Marker Sales by Type (2027-2032) & (K Units) Table 124. Global Cardiac Marker Sales Market Share by Type (2021-2026) Table 125. Global Cardiac Marker Sales Market Share by Type (2027-2032) Table 126. Global Cardiac Marker Revenue by Type (2021-2026) & (US$ Million) Table 127. Global Cardiac Marker Revenue by Type (2027-2032) & (US$ Million) Table 128. Global Cardiac Marker Revenue Market Share by Type (2021-2026) Table 129. Global Cardiac Marker Revenue Market Share by Type (2027-2032) Table 130. Global Cardiac Marker Price by Type (2021-2026) & (US$/Unit) Table 131. Global Cardiac Marker Price by Type (2027-2032) & (US$/Unit) Table 132. Global Cardiac Marker Sales by Application (2021-2026) & (K Units) Table 133. Global Cardiac Marker Sales by Application (2027-2032) & (K Units) Table 134. Global Cardiac Marker Sales Market Share by Application (2021-2026) Table 135. Global Cardiac Marker Sales Market Share by Application (2027-2032) Table 136. Global Cardiac Marker Revenue by Application (2021-2026) & (US$ Million) Table 137. Global Cardiac Marker Revenue by Application (2027-2032) & (US$ Million) Table 138. Global Cardiac Marker Revenue Market Share by Application (2021-2026) Table 139. Global Cardiac Marker Revenue Market Share by Application (2027-2032) Table 140. Global Cardiac Marker Price by Application (2021-2026) & (US$/Unit) Table 141. Global Cardiac Marker Price by Application (2027-2032) & (US$/Unit) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Cardiac Marker Distributors List Table 145. Cardiac Marker Customers List Table 146. Cardiac Marker Industry Trends Table 147. Cardiac Marker Industry Drivers Table 148. Cardiac Marker Industry Restraints Table 149. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Cardiac Marker Product Image Figure 5. Global Cardiac Marker Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Cardiac Marker Market Size (2021-2032) & (US$ Million) Figure 7. Global Cardiac Marker Sales (2021-2032) & (K Units) Figure 8. Global Cardiac Marker Average Price (US$/Unit) & (2021-2032) Figure 9. BNP & NT-proBNP Product Image Figure 10. Troponin (cTnI and cTnT) Product Image Figure 11. Myogloblin Product Image Figure 12. Creatine kinase (CK) MB Product Image Figure 13. Others (hs-CRP, D-Dimer, etc.) Product Image Figure 14. Myocardial Infarction Product Image Figure 15. Acute Coronary Syndrome Product Image Figure 16. Atherosclerosis Product Image Figure 17. Congestive Heart Failure Product Image Figure 18. Others Product Image Figure 19. Global Cardiac Marker Revenue Share by Manufacturers in 2025 Figure 20. Global Manufacturers of Cardiac Marker, Manufacturing Sites & Headquarters Figure 21. Global Top 5 and 10 Cardiac Marker Players Market Share by Revenue in 2025 Figure 22. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Cardiac Marker Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 24. Global Cardiac Marker Sales by Region in 2025 Figure 25. Global Cardiac Marker Revenue by Region in 2025 Figure 26. North America Cardiac Marker Market Size by Country in 2025 Figure 27. North America Cardiac Marker Sales Market Share by Country (2021-2032) Figure 28. North America Cardiac Marker Revenue Market Share by Country (2021-2032) Figure 29. United States Cardiac Marker Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Canada Cardiac Marker Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Europe Cardiac Marker Market Size by Country in 2025 Figure 32. Europe Cardiac Marker Sales Market Share by Country (2021-2032) Figure 33. Europe Cardiac Marker Revenue Market Share by Country (2021-2032) Figure 34. Germany Cardiac Marker Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. France Cardiac Marker Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. U.K. Cardiac Marker Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Italy Cardiac Marker Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Cardiac Marker Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Asia Pacific Cardiac Marker Market Size by Country in 2025 Figure 40. Asia Pacific Cardiac Marker Sales Market Share by Country (2021-2032) Figure 41. Asia Pacific Cardiac Marker Revenue Market Share by Country (2021-2032) Figure 42. China Cardiac Marker Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Japan Cardiac Marker Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South Korea Cardiac Marker Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. India Cardiac Marker Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Australia Cardiac Marker Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. China Taiwan Cardiac Marker Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Cardiac Marker Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Cardiac Marker Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South America Cardiac Marker Market Size by Country in 2025 Figure 51. South America Cardiac Marker Sales Market Share by Country (2021-2032) Figure 52. South America Cardiac Marker Revenue Market Share by Country (2021-2032) Figure 53. Mexico Cardiac Marker Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Brazil Cardiac Marker Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Cardiac Marker Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Middle East and Africa Cardiac Marker Market Size by Country in 2025 Figure 57. Middle East and Africa Cardiac Marker Sales Market Share by Country (2021-2032) Figure 58. Middle East and Africa Cardiac Marker Revenue Market Share by Country (2021-2032) Figure 59. Turkey Cardiac Marker Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Cardiac Marker Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. UAE Cardiac Marker Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Global Cardiac Marker Sales Market Share by Type (2021-2032) Figure 63. Global Cardiac Marker Revenue Market Share by Type (2021-2032) Figure 64. Global Cardiac Marker Price (US$/Unit) by Type (2021-2032) Figure 65. Global Cardiac Marker Sales Market Share by Application (2021-2032) Figure 66. Global Cardiac Marker Revenue Market Share by Application (2021-2032) Figure 67. Global Cardiac Marker Price (US$/Unit) by Application (2021-2032) Figure 68. Cardiac Marker Value Chain Figure 69. Cardiac Marker Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Cardiac Marker Industry Opportunities and Challenges

Scope & coverage.

Types
  • BNP & NT-proBNP
  • Troponin (cTnI and cTnT)
  • Myogloblin
  • Creatine kinase (CK) MB
  • Others (hs-CRP, D-Dimer, etc.)
Applications
  • Myocardial Infarction
  • Acute Coronary Syndrome
  • Atherosclerosis
  • Congestive Heart Failure
  • Others
Companies covered
  • BG Medicine
  • Biomerieux
  • Critical Diagnostics
  • DiaDexus
  • HyTest
  • Lee BioSolutions
  • Response Biomedical
  • Roche Diagnostics
  • Siemens Healthcare
  • Singulex
  • Sunfory
  • Thermo Scientific
  • Trinity Biotech
  • Abbott

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Cardiac Marker Market Size (2021-2032)
  4. 2.2.2 Global Cardiac Marker Sales (2021-2032)
  5. 2.2.3 Global Cardiac Marker Market Average Price (2021-2032)
  6. 2.3 Cardiac Marker by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 BNP & NT-proBNP
  9. 2.3.3 Troponin (cTnI and cTnT)
  10. 2.3.4 Myogloblin
  11. 2.3.5 Creatine kinase (CK) MB
  12. 2.3.6 Others (hs-CRP, D-Dimer, etc.)
  13. 2.4 Cardiac Marker by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 Myocardial Infarction
  16. 2.4.3 Acute Coronary Syndrome
  17. 2.4.4 Atherosclerosis
  18. 2.4.5 Congestive Heart Failure
  19. 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Cardiac Marker Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Cardiac Marker Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Cardiac Marker Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Cardiac Marker Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Cardiac Marker Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Cardiac Marker, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Cardiac Marker, Product Type & Application
  8. 3.8 Global Manufacturers of Cardiac Marker, Established Date
  9. 3.9 Global Cardiac Marker Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 BG Medicine
  2. 4.1.1 BG Medicine Company Information
  3. 4.1.2 BG Medicine Business Overview
  4. 4.1.3 BG Medicine Cardiac Marker Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 BG Medicine Cardiac Marker Product Portfolio
  6. 4.1.5 BG Medicine Recent Developments
  7. 4.2 Biomerieux
  8. 4.2.1 Biomerieux Company Information
  9. 4.2.2 Biomerieux Business Overview
  10. 4.2.3 Biomerieux Cardiac Marker Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Biomerieux Cardiac Marker Product Portfolio
  12. 4.2.5 Biomerieux Recent Developments
  13. 4.3 Critical Diagnostics
  14. 4.3.1 Critical Diagnostics Company Information
  15. 4.3.2 Critical Diagnostics Business Overview
  16. 4.3.3 Critical Diagnostics Cardiac Marker Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Critical Diagnostics Cardiac Marker Product Portfolio
  18. 4.3.5 Critical Diagnostics Recent Developments
  19. 4.4 DiaDexus
  20. 4.4.1 DiaDexus Company Information
  21. 4.4.2 DiaDexus Business Overview
  22. 4.4.3 DiaDexus Cardiac Marker Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 DiaDexus Cardiac Marker Product Portfolio
  24. 4.4.5 DiaDexus Recent Developments
  25. 4.5 HyTest
  26. 4.5.1 HyTest Company Information
  27. 4.5.2 HyTest Business Overview
  28. 4.5.3 HyTest Cardiac Marker Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 HyTest Cardiac Marker Product Portfolio
  30. 4.5.5 HyTest Recent Developments
  31. 4.6 Lee BioSolutions
  32. 4.6.1 Lee BioSolutions Company Information
  33. 4.6.2 Lee BioSolutions Business Overview
  34. 4.6.3 Lee BioSolutions Cardiac Marker Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Lee BioSolutions Cardiac Marker Product Portfolio
  36. 4.6.5 Lee BioSolutions Recent Developments
  37. 4.7 Response Biomedical
  38. 4.7.1 Response Biomedical Company Information
  39. 4.7.2 Response Biomedical Business Overview
  40. 4.7.3 Response Biomedical Cardiac Marker Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Response Biomedical Cardiac Marker Product Portfolio
  42. 4.7.5 Response Biomedical Recent Developments
  43. 4.8 Roche Diagnostics
  44. 4.8.1 Roche Diagnostics Company Information
  45. 4.8.2 Roche Diagnostics Business Overview
  46. 4.8.3 Roche Diagnostics Cardiac Marker Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Roche Diagnostics Cardiac Marker Product Portfolio
  48. 4.8.5 Roche Diagnostics Recent Developments
  49. 4.9 Siemens Healthcare
  50. 4.9.1 Siemens Healthcare Company Information
  51. 4.9.2 Siemens Healthcare Business Overview
  52. 4.9.3 Siemens Healthcare Cardiac Marker Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Siemens Healthcare Cardiac Marker Product Portfolio
  54. 4.9.5 Siemens Healthcare Recent Developments
  55. 4.10 Singulex
  56. 4.10.1 Singulex Company Information
  57. 4.10.2 Singulex Business Overview
  58. 4.10.3 Singulex Cardiac Marker Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Singulex Cardiac Marker Product Portfolio
  60. 4.10.5 Singulex Recent Developments
  61. 4.11 Sunfory
  62. 4.11.1 Sunfory Company Information
  63. 4.11.2 Sunfory Business Overview
  64. 4.11.3 Sunfory Cardiac Marker Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Sunfory Cardiac Marker Product Portfolio
  66. 4.11.5 Sunfory Recent Developments
  67. 4.12 Thermo Scientific
  68. 4.12.1 Thermo Scientific Company Information
  69. 4.12.2 Thermo Scientific Business Overview
  70. 4.12.3 Thermo Scientific Cardiac Marker Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Thermo Scientific Cardiac Marker Product Portfolio
  72. 4.12.5 Thermo Scientific Recent Developments
  73. 4.13 Trinity Biotech
  74. 4.13.1 Trinity Biotech Company Information
  75. 4.13.2 Trinity Biotech Business Overview
  76. 4.13.3 Trinity Biotech Cardiac Marker Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Trinity Biotech Cardiac Marker Product Portfolio
  78. 4.13.5 Trinity Biotech Recent Developments
  79. 4.14 Abbott
  80. 4.14.1 Abbott Company Information
  81. 4.14.2 Abbott Business Overview
  82. 4.14.3 Abbott Cardiac Marker Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Abbott Cardiac Marker Product Portfolio
  84. 4.14.5 Abbott Recent Developments
5 Global Cardiac Marker Market Scenario by Region
  1. 5.1 Global Cardiac Marker Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Cardiac Marker Sales by Region: 2021-2032
  3. 5.2.1 Global Cardiac Marker Sales by Region: 2021-2026
  4. 5.2.2 Global Cardiac Marker Sales by Region: 2027-2032
  5. 5.3 Global Cardiac Marker Revenue by Region: 2021-2032
  6. 5.3.1 Global Cardiac Marker Revenue by Region: 2021-2026
  7. 5.3.2 Global Cardiac Marker Revenue by Region: 2027-2032
  8. 5.4 North America Cardiac Marker Market Facts & Figures by Country
  9. 5.4.1 North America Cardiac Marker Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Cardiac Marker Sales by Country (2021-2032)
  11. 5.4.3 North America Cardiac Marker Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Cardiac Marker Market Facts & Figures by Country
  15. 5.5.1 Europe Cardiac Marker Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Cardiac Marker Sales by Country (2021-2032)
  17. 5.5.3 Europe Cardiac Marker Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Cardiac Marker Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Cardiac Marker Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Cardiac Marker Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Cardiac Marker Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Cardiac Marker Market Facts & Figures by Country
  35. 5.7.1 South America Cardiac Marker Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Cardiac Marker Sales by Country (2021-2032)
  37. 5.7.3 South America Cardiac Marker Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Cardiac Marker Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Cardiac Marker Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Cardiac Marker Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Cardiac Marker Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Cardiac Marker Sales by Type (2021-2032)
  2. 6.1.1 Global Cardiac Marker Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Cardiac Marker Sales Market Share by Type (2021-2032)
  4. 6.2 Global Cardiac Marker Revenue by Type (2021-2032)
  5. 6.2.1 Global Cardiac Marker Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Cardiac Marker Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Cardiac Marker Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Cardiac Marker Sales by Application (2021-2032)
  2. 7.1.1 Global Cardiac Marker Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Cardiac Marker Sales Market Share by Application (2021-2032)
  4. 7.2 Global Cardiac Marker Revenue by Application (2021-2032)
  5. 7.2.1 Global Cardiac Marker Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Cardiac Marker Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Cardiac Marker Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Cardiac Marker Value Chain Analysis
  2. 8.1.1 Cardiac Marker Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Cardiac Marker Production Mode & Process
  5. 8.2 Cardiac Marker Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Cardiac Marker Distributors
  8. 8.2.3 Cardiac Marker Customers
9 Global Cardiac Marker Analyzing Market Dynamics
  1. 9.1 Cardiac Marker Industry Trends
  2. 9.2 Cardiac Marker Industry Drivers
  3. 9.3 Cardiac Marker Industry Opportunities and Challenges
  4. 9.4 Cardiac Marker Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst